LTD4

Ltd4 is a lipid of Fatty Acyls (FA) class. Ltd4 is associated with abnormalities such as Inflammatory Bowel Diseases, Inflammatory disorder, Asthma, Pneumonia and Allergic asthma. The involved functions are known as inhibitors, Signal Transduction, Cell Survival, antagonists and Phosphorylation. Ltd4 often locates in Membrane, Tissue membrane, Protoplasm, Cytoplasmic matrix and membrane fraction. The associated genes with LTD4 are ALOX5 gene, UMOD gene, P4HTM gene, RAF1 gene and Homologous Gene. The related lipids are Lipopolysaccharides.

Cross Reference

Introduction

To understand associated biological information of LTD4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with LTD4?

LTD4 is suspected in Asthma, Inflammatory Bowel Diseases, Inflammatory disorder, Pneumonia, Allergic asthma, Virus Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with LTD4

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Adenocarcinoma D000230 166 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Edema D004487 152 associated lipids
Inflammation D007249 119 associated lipids
Glioma D005910 112 associated lipids
Weight Gain D015430 101 associated lipids
Seizures D012640 87 associated lipids
Stomach Ulcer D013276 75 associated lipids
Leukemia D007938 74 associated lipids
Reperfusion Injury D015427 65 associated lipids
Asthma D001249 52 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glomerulonephritis D005921 35 associated lipids
Neuralgia D009437 28 associated lipids
Gastritis D005756 27 associated lipids
Endotoxemia D019446 27 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Brain Edema D001929 20 associated lipids
Cough D003371 19 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Carotid Stenosis D016893 15 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Airway Obstruction D000402 13 associated lipids
Influenza, Human D007251 11 associated lipids
Rhinitis D012220 10 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Asthma, Exercise-Induced D001250 10 associated lipids
Inflammatory Bowel Diseases D015212 9 associated lipids
Otitis Media with Effusion D010034 9 associated lipids
Enteritis D004751 8 associated lipids
Asbestosis D001195 8 associated lipids
Sneezing D012912 6 associated lipids
Peptic Ulcer Hemorrhage D010438 4 associated lipids
Nasal Obstruction D015508 4 associated lipids
Respirovirus Infections D010253 3 associated lipids
Aspergillosis, Allergic Bronchopulmonary D001229 2 associated lipids
Per page 10 20 50 | Total 39

PubChem Associated disorders and diseases

What pathways are associated with LTD4

Lipid pathways are not clear in current pathway databases. We organized associated pathways with LTD4 through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with LTD4?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with LTD4?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with LTD4?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with LTD4?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with LTD4?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with LTD4

Download all related citations
Per page 10 20 50 100 | Total 640
Authors Title Published Journal PubMed Link
Francis HP et al. The effects of a novel sulphidopeptide leukotriene antagonist, BAY x7195, against elicited bronchoconstriction in the anaesthetized guinea-pig. 1998 Br. J. Pharmacol. pmid:9484852
Kohno S [Role of peptide-leukotrienes in bronchial asthma]. 1998 Nippon Yakurigaku Zasshi pmid:9618707
Gorenne I et al. Leukotriene D4 contractions in human airways are blocked by SK&F 96365, an inhibitor of receptor-mediated calcium entry. 1998 J. Pharmacol. Exp. Ther. pmid:9454796
Kimura K et al. Modulation of platelet activating factor-induced glycogenolysis in the perfused rat liver after administration of endotoxin in vivo. 1998 J. Biochem. pmid:9504421
Capra V et al. Identification and characterization of two cysteinyl-leukotriene high affinity binding sites with receptor characteristics in human lung parenchyma. 1998 Mol. Pharmacol. pmid:9547367
Dahlén B et al. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. 1998 Am. J. Respir. Crit. Care Med. pmid:9563738
Capra V et al. Pharmacological characterization of the cysteinyl-leukotriene antagonists CGP 45715A (iralukast) and CGP 57698 in human airways in vitro. 1998 Br. J. Pharmacol. pmid:9504401
Arakida Y et al. In vitro pharmacologic profile of YM158, a new dual antagonist for LTD4 and TXA2 receptors. 1998 J. Pharmacol. Exp. Ther. pmid:9808690
Venugopalan CS et al. Responses of guinea-pig lung parenchymal strips to tracheobronchial lavage fluid from horses affected with summer pasture-associated obstructive pulmonary disease. 1998 Vet. Res. Commun. pmid:9868763
Chambers RJ et al. Development of new chromanol antagonists of leukotriene D4. 1998 Bioorg. Med. Chem. Lett. pmid:9873435
Nagayama S et al. Increased sensitivity to vincristine of MDR cells by the leukotriene D4 receptor antagonist, ONO-1078. 1998 Cancer Lett. pmid:9751271
Kim N et al. Leukotriene D4-induced contraction of cat esophageal and lower esophageal sphincter circular smooth muscle. 1998 Gastroenterology pmid:9753495
Grönroos E et al. Leukotriene D4 induces a rapid increase in cAMP in the human epithelial cell line, Int 407: a potential role for this signal in the regulation of calcium influx through the plasma membrane. 1998 Cell Calcium pmid:9793684
Tsang F et al. Effects of mitogen-activated protein kinase kinase inhibitor PD 098059 on antigen challenge of guinea-pig airways in vitro. 1998 Br. J. Pharmacol. pmid:9776345
Panettieri RA et al. Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction In vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. 1998 Am. J. Respir. Cell Mol. Biol. pmid:9730873
Lane SJ Leukotriene antagonism in asthma and rhinitis. 1998 Respir Med pmid:9850362
Smith LJ et al. A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy. 1998 Ann. Allergy Asthma Immunol. pmid:9690572
Kjellström S et al. On-line coupling of microdialysis sampling with liquid chromatography for the determination of peptide and non-peptide leukotrienes. 1998 J Chromatogr A pmid:9818423
Ohbayashi H et al. Neutral endopeptidase 3.4.24.11 inhibition potentiates the inhibitory effects of type-C natriuretic peptide on leukotriene D4-induced airway changes. 1998 Clin. Exp. Pharmacol. Physiol. pmid:9887994
Underwood DC et al. Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pig. 1998 J. Pharmacol. Exp. Ther. pmid:9864284
Fujimura M et al. A partial involvement of histamine in ultrasonically nebulized distilled water-induced bronchoconstriction in guinea-pigs. 1998 Br. J. Pharmacol. pmid:9831931
Kawashima Y et al. Surface-modified antiasthmatic dry powder aerosols inhaled intratracheally reduce the pharmacologically effective dose. 1998 Pharm. Res. pmid:9833999
Allen S et al. Differential leukotriene constrictor responses in human atherosclerotic coronary arteries. 1998 Circulation pmid:9641692
Sato E et al. Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity. 1998 Am. J. Physiol. pmid:9609736
Aharony D Pharmacology of leukotriene receptor antagonists 1998 Am. J. Respir. Crit. Care Med. pmid:9620942
Daugschies A and Ruttkowski B Modulation of migration of Oesophagostomum dentatum larvae by inhibitors and products of eicosanoid metabolism. 1998 Int. J. Parasitol. pmid:9513001
Pedersen KE et al. Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism. 1997 J. Pharmacol. Exp. Ther. pmid:9152370
Beckh K et al. Impairment of hepatic transport processes in perfused rat liver by the specific CCK receptor antagonist loxiglumide. 1997 Res Exp Med (Berl) pmid:9406280
Cincu RN et al. S-adenosyl-L-methionine protects the liver against the cholestatic, cytotoxic, and vasoactive effects of leukotriene D4: a study with isolated and perfused rat liver. 1997 Hepatology pmid:9252142
Goldhill J et al. Interleukin-4 modulates cholinergic neural control of mouse small intestinal longitudinal muscle. 1997 Am. J. Physiol. pmid:9176223
Sakurai S et al. Synthesis and dual antagonistic activity against thromboxane A2 and leukotriene D4 of [4-[1-(benzenesulfonamido)alkyl]phenyl]alkanoic acid derivatives. 1997 Chem. Pharm. Bull. pmid:9178522
Spector SL Leukotriene activity modulation in asthma. 1997 Drugs pmid:9279501
Sakurai S et al. [Synthesis and dual antagonistic activity against thromboxane A2 and leukotriene D4 of benzenesulfonamide derivatives]. 1997 Yakugaku Zasshi pmid:9194397
O'Shaughnessy TC et al. Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers. 1997 Thorax pmid:9227717
Meng XJ et al. Leukotriene D4 activates a chloride conductance in hepatocytes from lipopolysaccharide-treated rats. 1997 J. Clin. Invest. pmid:9185515
Zhang MQ and Timmerman H Leukotriene cysLT1 (LTD4) receptor antagonism of H1-antihistamines: an in vitro study. 1997 Inflamm. Res. pmid:9098782
Wang Y et al. Induction of LTD in the dentate gyrus in vitro is NMDA receptor independent, but dependent on Ca2+ influx via low-voltage-activated Ca2+ channels and release of Ca2+ from intracellular stores. 1997 J. Neurophysiol. pmid:9065852
Dumitriu D et al. Mechanism of action of leukotriene D4 on guinea pig tracheal smooth muscle cells: roles of Ca++ influx and intracellular Ca++ release. 1997 J. Pharmacol. Exp. Ther. pmid:9067324
Maehr H and Yang R Structure optimization of a leukotriene D4 antagonist by combinatorial chemistry in solution. 1997 Bioorg. Med. Chem. pmid:9113326
Joki S and Saano V Influence of ageing on ciliary beat frequency and on ciliary response to leukotriene D4 in guinea-pig tracheal epithelium. 1997 Clin. Exp. Pharmacol. Physiol. pmid:9075591
Uno T et al. Participation of leukotriene D4 and tumor necrosis factor on lipopolysaccharide-induced airway hyperresponsiveness in guinea pigs. 1997 Biol. Pharm. Bull. pmid:9145204
Diamant Z et al. The effect of inhaled leukotriene D4 and methacholine on sputum cell differentials in asthma. 1997 Am. J. Respir. Crit. Care Med. pmid:9105062
Pedersen S et al. Leukotriene D4-induced Ca2+ mobilization in Ehrlich ascites tumor cells. 1997 J. Membr. Biol. pmid:9002425
Ohd JF et al. Leukotriene D4-induced signalling events in human epithelial cells: G alpha i3 activation and translocation. 1997 Adv. Exp. Med. Biol. pmid:9561113
von Sprecher A et al. CGP57698: a structurally simple, highly potent peptido-leukotriene (pLT) antagonist of the quinoline type. 1997 Adv. Exp. Med. Biol. pmid:9561127
Honda I et al. Tachykinin antagonist FK224 inhibits neurokinin A-, substance P- and capsaicin-induced human bronchial contraction. 1997 Fundam Clin Pharmacol pmid:9243258
Kanli H and Terreros DA Transepithelial transport and cell volume control in proximal renal tubules from the teleost Carassius auratus. 1997 Acta Physiol. Scand. pmid:9246390
Wong WS et al. Effects of tyrosine kinase inhibitors on antigen challenge of guinea pig lung in vitro. 1997 J. Pharmacol. Exp. Ther. pmid:9336317
Cibulsky SM and Thompson DC Absence of tachykinin involvement in leukotriene D4 and antigen-induced contraction of guinea pig isolated bronchus. 1997 J. Pharmacol. Exp. Ther. pmid:9399982
Muñoz NM et al. Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism. 1997 Am. J. Respir. Crit. Care Med. pmid:9105085